VFVivian Rachel Feig

Vivian Rachel Feig

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vivian Rachel Feig has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Aaron Lopes

    Division of Gastroenterology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA

    1 shared publication
  • Andrew Pettinari

    Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, USA

    1 shared publication
  • Ashka Patel

    Division of Gastroenterology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA

    1 shared publication
  • Ashley Guevara

    Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, USA

    1 shared publication
  • Ayten E. Erdogan

    Division of Gastroenterology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA

    1 shared publication
  • Benjamin Muller

    Division of Gastroenterology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA

    1 shared publication

Latest Publications

  • Open Access

    Self-aggregating long-acting injectable microcrystals

    by Vivian R. Feig, Sanghyun Park, Pier Giuseppe Rivano, Jinhee Kim, Benjamin Muller, Ashka Patel, Caroline Dial, Sofia Gonzalez, Hannah Carlisle, Flavia Codreanu, et al.

    Injectable drug depots have transformed our capacity to enhance medication adherence through dose simplification. Central to patient adoption of injectables is the acceptability of needle injections, with needle gauge as a key factor informing patient discomfort. Maximizing drug loading in injectables supports longer drug release while reducing injection volume and discomfort. Here, to address these requirements, we developed self-aggregating long-acting injectable microcrystals (SLIM), an injectable formulation containing drug microcrystals that self-aggregate in the subcutaneous space to form a monolithic implant with a low ratio of polymer excipient to drug (0.0625:1 w/w). By minimizing polymer content, SLIM supports injection through low-profile needles (−1). We demonstrate in vitro and in vivo that self-aggregation is driven by solvent exchange at the injection site and that slower-exchanging solvents result in increased microcrystal compaction and reduced implant porosity. We further show that self-aggregation enhances long-term drug release in rodents. We anticipate that SLIM could enable low-cost interventions for contraceptives.


  • Biodegradable and stretchable polymeric materials for transient electronic devices

    by Kathy Liu, Helen Tran, Vivian Rachel Feig, Zhenan Bao